polyethylene glycol 3350
Generic: polyethylene glycol 3350
Labeler: glenmark therapeutics inc., usaDrug Facts
Product Profile
Brand Name
polyethylene glycol 3350
Generic Name
polyethylene glycol 3350
Labeler
glenmark therapeutics inc., usa
Dosage Form
POWDER, FOR SOLUTION
Routes
Active Ingredients
polyethylene glycol 3350 17 g/17g
Manufacturer
Identifiers & Regulatory
Product NDC
72657-196
Product ID
72657-196_7c2e19af-e03f-4d48-bac6-2efd716b70b3
Product Type
HUMAN OTC DRUG
Marketing Category
ANDA
Application Number
ANDA203928
Listing Expiration
2027-12-31
Marketing Start
2024-09-19
Pharmacologic Class
Established (EPC)
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72657196
Hyphenated Format
72657-196
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
polyethylene glycol 3350 (source: ndc)
Generic Name
polyethylene glycol 3350 (source: ndc)
Application Number
ANDA203928 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 17 g/17g
Packaging
- 765 g in 1 CAN (72657-196-16)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "7c2e19af-e03f-4d48-bac6-2efd716b70b3", "openfda": {"nui": ["N0000010288", "N0000175811", "N0000009871"], "upc": ["0359556762079"], "unii": ["G2M7P15E5P"], "rxcui": ["876193"], "spl_set_id": ["5aba6bb1-d25d-4901-8e9c-4cd4a3a06471"], "pharm_class_pe": ["Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "pharm_class_epc": ["Osmotic Laxative [EPC]"], "pharm_class_moa": ["Osmotic Activity [MoA]"], "manufacturer_name": ["GLENMARK THERAPEUTICS INC., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "765 g in 1 CAN (72657-196-16)", "package_ndc": "72657-196-16", "marketing_start_date": "20240919"}], "brand_name": "Polyethylene Glycol 3350", "product_id": "72657-196_7c2e19af-e03f-4d48-bac6-2efd716b70b3", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "72657-196", "generic_name": "Polyethylene Glycol 3350", "labeler_name": "GLENMARK THERAPEUTICS INC., USA", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Polyethylene Glycol 3350", "active_ingredients": [{"name": "POLYETHYLENE GLYCOL 3350", "strength": "17 g/17g"}], "application_number": "ANDA203928", "marketing_category": "ANDA", "marketing_start_date": "20240919", "listing_expiration_date": "20271231"}